The House of Representatives continues to keep the discussion of legal cannabis alive. Wednesday, January 15th the Energy and Commerce Subcommittee on Health will discuss measures, which include several proposals aimed at promoting research into cannabis. But while advocates view the development as a positive step, there are some concerns about the fact that only officials from the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA) and National Institute on Drug Abuse (NIDA) were invited to testify.
Among the legislation being discussed will be proposed bills addressing the use of medical marijuana, research, the removal of cannabis from the schedule of controlled substances, and investment in communities adversely affected by the war on drugs. You can follow the links below to read what each bill proposes.
H.R. 601, the “Medical Cannabis Research Act of 2019”
H.R. 171, the “Legitimate Use of Medicinal Marihuana Act” or the “LUMMA”
H.R. 1151, the “Veterans Medical Marijuana Safe Harbor Act”
H.R. 2843, the “Marijuana Freedom and Opportunity Act”
H.R. 3797, the “Medical Marijuana Research Act of 2019”
H.R. 3884, the “Marijuana Opportunity Reinvestment and Expungement Act of 2019” or the “MORE